z-logo
open-access-imgOpen Access
Leukemia inhibitory factor is involved in the pathogenesis of NSCLC through activation of the STAT3 signaling pathway
Author(s) -
Huaying Wang,
Sai'nv Si,
Mingjun Jiang,
Liping Chen,
Kefeng Huang,
Wanjun Yu
Publication year - 2021
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2021.12924
Subject(s) - leukemia inhibitory factor , stat3 , cancer research , stat protein , oncogene , a549 cell , lung cancer , adenocarcinoma , cell cycle , cell , signal transduction , biology , cancer , medicine , oncology , immunology , cytokine , microbiology and biotechnology , interleukin 6 , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom